Question 1

What is Monopar Therapeutics's short-term investments?

Accepted Answer

Monopar Therapeutics (MNPR) reported short-term investments of $52.37M in Q1 2026.

Question 2

How has Monopar Therapeutics's short-term investments changed year-over-year?

Accepted Answer

Monopar Therapeutics's short-term investments increased by 32.5% year-over-year, from $39.51M to $52.37M.

Question 3

What is the long-term trend for Monopar Therapeutics's short-term investments?

Accepted Answer

Over 3 years (2022 to 2025), Monopar Therapeutics's short-term investments has grown at a 71.0% compound annual growth rate (CAGR), from $12.18M to $60.88M.

Question 4

What does short-term investments mean?

Accepted Answer

Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.

As of March 31, 2026	Cost Basis	Unrealized Gains	Unrealized Losses	Aggregate Fair Value
U.S. Treasury Securities	$7,759,050	$30,732	—	$7,789,782
Commercial Paper	41,045,555	93,906	—	41,139,461
Money Market Accounts	3,440,048	—	—	3,440,048
Total	$52,244,653	$124,638	—	$52,369,292

Short-Term Investments at other companies

Other financials

Income statement

Balance sheet

Cash flow

Valuation

Returns & leverage

Where this comes from

FAQ

Ask your AI about Monopar Therapeutics's short-term investments.

Monopar Therapeutics MNPR Short-Term Investments